Market research
MDX.V MedX Health Corp
V CAD Healthcare
Latest close
Loading market data…
Test a moving-average rule with historical data.
- Market cap
- 16M
- P/E ratio
- Not available
- Analyst target
- 0.28
- Dividend yield
- Not available
- Beta
- 1.8
Profile
Company facts
- Exchange
- V
- Currency
- CAD
- Sector
- Healthcare
- Industry
- Medical Devices
- ISIN
- CA5850901037
- Market cap
- 16M
- P/E ratio
- Not available
- Analyst target
- 0.28
- Dividend yield
- Not available
- Beta
- 1.8
About
About MedX Health Corp
MedX Health Corp develops, manufactures, and markets skin related screening tools and phototherapy devices for pain relief and tissue repair in Canada, the United States, Europe, and internationally. The company offers SIAscopy, a medical device technology used to scan skin for suspicious moles and lesions; and phototherapeutic medical devices, which use light energy in lower-level laser and LED to provide effective treatment of pain and tissue damage in the rehabilitation market. It also provides DermSecure, a telemedicine software application. In addition, the company offers MedX rehab console system, rehab portable laser, and home unit; OraLase, a dental PBM laser; and veterinary-specific lasers. MedX Health Corp was incorporated in 1999 and is headquartered in Mississauga, Canada.
Visit company websiteCommunity
Investor discussion
1 comment
Sign in to join the MDX.V discussion.
5 years, 5 months ago
MedX Health Corp is currently in a long term downtrend where the price is trading 13.3% below its 200 day moving average.
From a valuation standpoint, the stock is 94.2% cheaper than other stocks from the Healthcare sector with a price to sales ratio of 59.5.
MedX Health Corp's total revenue sank by 26.4% to $173K since the same quarter in the previous year.
Its net income has dropped by 87.6% to $-1M since the same quarter in the previous year.
Finally, its free cash flow fell by 247.5% to $-590K since the same quarter in the previous year.
Based on the above factors, MedX Health Corp gets an overall score of 1/5.